BPIM
DMTK

Brant Point Investment Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Brant Point Investment Management’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-45,000
Closed -$2.29M – 161
2021
Q1 		$2.29M Sell
45,000
-10,000
-18% -$523K 0.25% 114
2020
Q4 		$1.78M Buy
+55,000
New +$780K 0.21% 119

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Brant Point Investment Management's DMTK Position: Q2 2021 in Review

Brant Point Investment Management sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2021, closing a stake of 45,000 shares — an estimated $2.29M sold.

Brant Point Investment Management first reported a position in DMTK in Q4 2020 and held it in 2 quarters. The position peaked at $2.29M in Q1 2021. 176 funds tracked by Wall St. Rank hold DMTK as of Q2 2021.

  • Brant Point Investment Management reported no remaining DermTech, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Brant Point Investment Management sold 45,000 DermTech, Inc. Common Stock shares in Q2 2021, an estimated $2.29M.
  • Brant Point Investment Management first reported a position in DermTech, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Brant Point Investment Management's DermTech, Inc. Common Stock position peaked at $2.29M in Q1 2021.
  • 176 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2021.

Based on Brant Point Investment Management's 13F filing for Q2 2021, filed 13 Aug 2021.